Michael Rapp is Director of Immunome Inc.. Currently has a direct ownership of 1.07 Million shares of IMNM, which is worth approximately $15.5 Million. The most recent transaction as insider was on Oct 02, 2023, when has been sold 253,806 shares (Common Stock) at a price of $5.91 per share, resulting in proceeds of $1,499,993. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.07M
0% 3M change
31.05% 12M change
Total Value Held $15.5 Million

MICHAEL RAPP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2023
BUY
Grant, award, or other acquisition
$1,499,993 $5.91 p/Share
253,806 Added 19.16%
1,071,172 Common Stock
Jan 15 2023
BUY
Grant, award, or other acquisition
$70,000 $4.0 p/Share
17,500 Added 2.1%
817,366 Common Stock
Oct 06 2020
BUY
Open market or private purchase
$999,984 $12.0 p/Share
83,332 Added 11.54%
638,886 Common Stock
Oct 06 2020
BUY
Conversion of derivative security
-
555,554 Added 50.0%
555,554 Common Stock
MR

Michael Rapp

Director
Exton, PA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM